You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
27 June 2025 - Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced late Thursday that the US Food and Drug Administration has approved updated labels for its two CAR T cell therapies, reducing patient monitoring requirements and remov...
27 June 2025 - Porton Advanced Solutions, a US-based global cell and gene therapy CDMO service provider, and EVA Pharma, an Egypt-based pharmaceutical company, announced on Thursday the signing of Memorandum of Understanding (MOU) to collaborate on e...
26 June 2025 - Biovica International AB (Nasdaq First North Premier Growth Market:BIOVIC-B), a supplier of blood-based biomarker assays to monitor cancer progression, revealed on Thursday that it has been granted a new patent by the European Patent O...
26 June 2025 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) said on Thursday that it has entered into an exclusive agreement with influenza vaccine company CSL Seqirus for the marketing and distribution of its three proprietary vacci...
26 June 2025 - Accord Healthcare Inc, a US-based generic pharmaceutical company, announced on Wednesday that it has added Dehydrated Alcohol Injection to its line of cardiovascular drugs.Accord's product is AB-rated to BPI Labs' Ablysinol a...
26 June 2025 - US medical device and pharmaceutical company Speranza Therapeutics on Wednesday announced a strategic partnership with Canada-based Sunshine Labs, which specialises in harm reduction, safer supply, and science-backed therapeutic innova...
26 June 2025 - CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a China-based company involved in developing innovative CAR T-cell therapies, announced on Wednesday that the National Medical Products Administration (NMPA) of China has acc...